down arrow

P & G Health Ltd

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,222.95
35.45 (0.68%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.15 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

5,184.005,245.00

52 Week

4,640.305,835.95
Valuation
Technical
Day's Volume

CASH

2.15 k (-24.84%) Volume

Shareholding (Dec 2024)

FII

7.02%

Held by 123 FIIs

DII

14.71%

Held by 15 DIIs

Promoter

51.82%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 30.22%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 4.59% and Operating profit at 11.95% over the last 5 years

 
4

Positive results in Dec 24

5

Technical trend is Sideways signifying no clear price momentum

6

With ROE of 41.2, it has a Very Expensive valuation with a 14.1 Price to Book Value

7

High Institutional Holdings at 21.73%

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 8,670 Cr (Mid Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

2.70%

stock-summary
Debt Equity

-0.43

stock-summary
Return on Equity

41.18%

stock-summary
Price to Book

14.11

Revenue and Profits (1 Year):
Net Sales:
310 Cr
(Quarterly Results - Dec 2024)
Net Profit:
91 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.7%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-0.08%
2.81%
2.73%
1 Year
8.86%
2.91%
11.77%
2 Years
7.44%
5.09%
12.53%
3 Years
19.69%
6.92%
26.61%
4 Years
-17.91%
7.33%
-10.58%
5 Years
17.56%
12.02%
29.58%

Latest dividend: 80 per share ex-dividend date: Feb-21-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.59%
EBIT Growth (5y)
11.95%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.58
Tax Ratio
25.76%
Dividend Payout Ratio
214.75%
Pledged Shares
0
Institutional Holding
21.73%
ROCE (avg)
80.75%
ROE (avg)
30.22%
Valuation key factors
Factor
Value
P/E Ratio
34
Industry P/E
33
Price to Book Value
14.11
EV to EBIT
25.46
EV to EBITDA
23.63
EV to Capital Employed
24.12
EV to Sales
7.20
PEG Ratio
3.14
Dividend Yield
2.70%
ROCE (Latest)
94.75%
ROE (Latest)
41.18%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (10.64%)

FIIs

Held by 123 FIIs (7.02%)

Promoter with highest holding

Procter And Gamble Overseas India B.v. (51.82%)

Highest Public shareholder

Nippon Life India Trustee Ltd-a/c Nippon India Sma (4.1%)

Individual Investors Holdings

21.34%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -0.06% vs 0.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 26.13% vs -6.16% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "309.77",
          "val2": "309.97",
          "chgp": "-0.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "123.43",
          "val2": "101.65",
          "chgp": "21.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.15",
          "val2": "0.19",
          "chgp": "-21.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "90.90",
          "val2": "72.07",
          "chgp": "26.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "39.85%",
          "val2": "32.79%",
          "chgp": "7.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Dec 2024 is 1.35% vs 1.21% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Dec 2024 is 25.86% vs -2.01% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "623.18",
          "val2": "614.90",
          "chgp": "1.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "237.47",
          "val2": "190.31",
          "chgp": "24.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.37",
          "chgp": "-18.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "173.23",
          "val2": "137.64",
          "chgp": "25.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.11%",
          "val2": "30.95%",
          "chgp": "7.16%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Mar 2024 is -6.58% vs 13.43% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Mar 2024 is -7.74% vs 31.90% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "867.38",
          "val2": "928.44",
          "chgp": "-6.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "257.75",
          "val2": "279.34",
          "chgp": "-7.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.52",
          "val2": "0.60",
          "chgp": "-13.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "184.20",
          "val2": "199.65",
          "chgp": "-7.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.72%",
          "val2": "30.09%",
          "chgp": "-0.37%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is -6.37% vs 10.34% in Jun 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is -12.42% vs 19.19% in Jun 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,151.26",
          "val2": "1,229.62",
          "chgp": "-6.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "306.00",
          "val2": "324.68",
          "chgp": "-5.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.72",
          "val2": "0.77",
          "chgp": "-6.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-20.19",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "200.98",
          "val2": "229.47",
          "chgp": "-12.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.58%",
          "val2": "26.40%",
          "chgp": "0.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
309.77
309.97
-0.06%
Operating Profit (PBDIT) excl Other Income
123.43
101.65
21.43%
Interest
0.15
0.19
-21.05%
Exceptional Items
0.00
0.00
Standalone Net Profit
90.90
72.07
26.13%
Operating Profit Margin (Excl OI)
39.85%
32.79%
7.06%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -0.06% vs 0.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 26.13% vs -6.16% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
623.18
614.90
1.35%
Operating Profit (PBDIT) excl Other Income
237.47
190.31
24.78%
Interest
0.30
0.37
-18.92%
Exceptional Items
0.00
0.00
Standalone Net Profit
173.23
137.64
25.86%
Operating Profit Margin (Excl OI)
38.11%
30.95%
7.16%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Dec 2024 is 1.35% vs 1.21% in Dec 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Dec 2024 is 25.86% vs -2.01% in Dec 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
867.38
928.44
-6.58%
Operating Profit (PBDIT) excl Other Income
257.75
279.34
-7.73%
Interest
0.52
0.60
-13.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
184.20
199.65
-7.74%
Operating Profit Margin (Excl OI)
29.72%
30.09%
-0.37%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Mar 2024 is -6.58% vs 13.43% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Mar 2024 is -7.74% vs 31.90% in Mar 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Jun'24stock-summary
Jun'24
Jun'23
Change(%)
Net Sales
1,151.26
1,229.62
-6.37%
Operating Profit (PBDIT) excl Other Income
306.00
324.68
-5.75%
Interest
0.72
0.77
-6.49%
Exceptional Items
-20.19
0.00
Standalone Net Profit
200.98
229.47
-12.42%
Operating Profit Margin (Excl OI)
26.58%
26.40%
0.18%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2024 is -6.37% vs 10.34% in Jun 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Jun 2024 is -12.42% vs 19.19% in Jun 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Procter & Gamble Health Ltd stock-summary
stock-summary
Procter & Gamble Health Ltd
Mid Cap
Pharmaceuticals & Drugs
Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in year 1967. The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002. Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019. The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
Company Coordinates stock-summary
Company Details
Godrej One 8th Floor, Projshanagar Vikhroli (East) Mumbai Maharashtra : 400079
stock-summary
Tel: 91-22-62109000
stock-summary
http://www.pghealthindia.com
stock-summary
investorgrievance.im@pg.com
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."